The OsteoSponge is approved for use as a subchondral bone void filler by the FDA. The product is an acellular matrix scaffold made from donated human bone that replaces the patient’s damaged bone.
The device, which is used during a minimally invasive procedure, is designed to allow the surgeon to incorporate the patient’s own stem cells or bioactive agents to accelerate tissue regeneration.
Read the release on OsteoSponge from Bacterin.
Read other coverage on orthopedic and spine devices:
– DePuy Mitek Launches Rotator Cuff Repair System & Radiofrequency Technology
– Lanx Launches Epic Anterior Thoracolumbar Plating System
– ArthroCare Receives FDA 510(k) Clearance on Spartan 5.5 Needle Anchor
